109 related articles for article (PubMed ID: 25381141)
1. Histone deacetylase inhibitors for enhancing activity of antifungal agent: a patent evaluation of WO2014041424(A1).
Zhang L; Xu W
Expert Opin Ther Pat; 2015 Feb; 25(2):237-40. PubMed ID: 25381141
[TBL] [Abstract][Full Text] [Related]
2. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
[TBL] [Abstract][Full Text] [Related]
3. Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans.
Mai A; Rotili D; Massa S; Brosch G; Simonetti G; Passariello C; Palamara AT
Bioorg Med Chem Lett; 2007 Mar; 17(5):1221-5. PubMed ID: 17196388
[TBL] [Abstract][Full Text] [Related]
4. Potent antifungal activity of extracts and pure compound isolated from pomegranate peels and synergism with fluconazole against Candida albicans.
Endo EH; Cortez DA; Ueda-Nakamura T; Nakamura CV; Dias Filho BP
Res Microbiol; 2010 Sep; 161(7):534-40. PubMed ID: 20541606
[TBL] [Abstract][Full Text] [Related]
5. Novel hybrids of fluconazole and furanones: design, synthesis and antifungal activity.
Borate HB; Sawargave SP; Chavan SP; Chandavarkar MA; Iyer R; Tawte A; Rao D; Deore JV; Kudale AS; Mahajan PS; Kangire GS
Bioorg Med Chem Lett; 2011 Aug; 21(16):4873-8. PubMed ID: 21757344
[TBL] [Abstract][Full Text] [Related]
6. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
[TBL] [Abstract][Full Text] [Related]
8. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species.
Pfaller MA; Rhomberg PR; Messer SA; Castanheira M
Diagn Microbiol Infect Dis; 2015 Apr; 81(4):259-63. PubMed ID: 25600842
[TBL] [Abstract][Full Text] [Related]
10. Reversal of fluconazole resistance induced by a synergistic effect with Acca sellowiana in Candida glabrata strains.
R M Machado GD; Pippi B; Dalla Lana DF; Amaral AP; Teixeira ML; Souza KC; Fuentefria AM
Pharm Biol; 2016 Nov; 54(11):2410-2419. PubMed ID: 27050162
[TBL] [Abstract][Full Text] [Related]
11. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole].
Kurnatowski P; Makieło L; Horwatt-Bozyczko E
Wiad Parazytol; 2001; 47(4):867-73. PubMed ID: 16886440
[TBL] [Abstract][Full Text] [Related]
12. Preparations of liposomal fluconazole and their in vitro antifungal activity.
Singh M; Singh MP; Maiti SN; Gandhi A; Micetich RG; Atwal H
J Microencapsul; 1993; 10(2):229-36. PubMed ID: 8331496
[TBL] [Abstract][Full Text] [Related]
13. Synergistic mutual potentiation of antifungal activity of Zuccagnia punctata Cav. and Larrea nitida Cav. extracts in clinical isolates of Candida albicans and Candida glabrata.
Butassi E; Svetaz LA; Ivancovich JJ; Feresin GE; Tapia A; Zacchino SA
Phytomedicine; 2015 Jun; 22(6):666-78. PubMed ID: 26055132
[TBL] [Abstract][Full Text] [Related]
14. Discovery of BRD4-HDAC Dual Inhibitors with Improved Fungal Selectivity and Potent Synergistic Antifungal Activity against Fluconazole-Resistant
Li Z; Huang Y; Tu J; Yang W; Liu N; Wang W; Sheng C
J Med Chem; 2023 Apr; 66(8):5950-5964. PubMed ID: 37037787
[TBL] [Abstract][Full Text] [Related]
15. Quinazolinone fungal efflux pump inhibitors. Part 2: In vitro structure-activity relationships of (N-methyl-piperazinyl)-containing derivatives.
Watkins WJ; Lemoine RC; Chong L; Cho A; Renau TE; Kuo B; Wong V; Ludwikow M; Garizi N; Iqbal N; Barnard J; Jankowska R; Singh R; Madsen D; Lolans K; Lomovskaya O; Oza U; Dudley MN
Bioorg Med Chem Lett; 2004 Oct; 14(20):5133-7. PubMed ID: 15380214
[TBL] [Abstract][Full Text] [Related]
16. In vitro antifungal susceptibility testing of Candida blood isolates and evaluation of the E-test method.
Lu JJ; Lee SY; Chiueh TS
J Microbiol Immunol Infect; 2004 Dec; 37(6):335-42. PubMed ID: 15599465
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2005 Nov; 43(11):5425-7. PubMed ID: 16272464
[TBL] [Abstract][Full Text] [Related]
18. In vitro antifungal activity of the berberine and its synergism with fluconazole.
Iwazaki RS; Endo EH; Ueda-Nakamura T; Nakamura CV; Garcia LB; Filho BP
Antonie Van Leeuwenhoek; 2010 Feb; 97(2):201-5. PubMed ID: 19882381
[TBL] [Abstract][Full Text] [Related]
19. Antifungal effect of high- and low-molecular-weight chitosan hydrochloride, carboxymethyl chitosan, chitosan oligosaccharide and N-acetyl-D-glucosamine against Candida albicans, Candida krusei and Candida glabrata.
Seyfarth F; Schliemann S; Elsner P; Hipler UC
Int J Pharm; 2008 Apr; 353(1-2):139-48. PubMed ID: 18164151
[TBL] [Abstract][Full Text] [Related]
20. Curcumin as a promising anticandidal of clinical interest.
Neelofar K; Shreaz S; Rimple B; Muralidhar S; Nikhat M; Khan LA
Can J Microbiol; 2011 Mar; 57(3):204-10. PubMed ID: 21358761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
